F2 and COVID-19: In Chinese, Italian and French cohorts of COVID-19-affected patients, a substantial increase in D-dimer and fibrin degradation products, along with a longer prothrombin time and activated partial thromboplastin time has additionally been documented as compared to uninfected patients [18, 20, 22].